Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line
NeoStem (AMEX:NBS) announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received…
Workplace Wellness Meets in the Middle of the Aisle
Congress is taking note of the need for workplace wellness, and elected…
Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, 2010-2020
Publishing in June, The MedMarket Diligence Report #M520, "Worldwide Spine Surgery 2011:…
Grand Rounds Vol. 7 No. 38
When I first hosted Grand Rounds six years ago, the iPhone, iPad…
Why Don’t Patients Hit the Panic Button in Hospitals? Lessons from Condition H
Today’s Hospitalist (Ready to let patients hit the panic button?) describes the…
Two Approaches to Controlling Drug Costs
The Medicaid Drug Rebate Program has been around for 20 years. It…
Michigan’s Medical Marijuana Shows an $8 Million Dollar Profit
This is not bad for a state that is looking for revenue…
Is Technology a Cost Driver or a Cost Saver in Health Care?
Pharmaceutical, biotechnology, and medical-device and equipment companies have been extremely effective at…
The Stunning Shift Toward Employed Physicians
I’m amazed at just how quickly physician employment has swung from small…
Navigating the Perilous Road: A Special Panel On Regulatory and Reimbursement Issues
The US market represents huge profit potential for an innovative company, but…